Biomed Realty Trust (NYSE: BMR) is one of 75 public companies in the “Commercial REITs” industry, but how does it contrast to its rivals? We will compare Biomed Realty Trust to similar businesses based on the strength of its valuation, dividends, risk, profitability, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of current recommendations for Biomed Realty Trust and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomed Realty Trust 0 0 0 0 N/A
Biomed Realty Trust Competitors 640 2616 2241 24 2.30

As a group, “Commercial REITs” companies have a potential upside of 1.09%. Given Biomed Realty Trust’s rivals higher possible upside, analysts plainly believe Biomed Realty Trust has less favorable growth aspects than its rivals.

Earnings and Valuation

This table compares Biomed Realty Trust and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Biomed Realty Trust N/A N/A 22.89
Biomed Realty Trust Competitors $537.63 million $101.41 million 416.73

Biomed Realty Trust’s rivals have higher revenue and earnings than Biomed Realty Trust. Biomed Realty Trust is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Dividends

Biomed Realty Trust pays an annual dividend of $1.04 per share and has a dividend yield of 4.4%. Biomed Realty Trust pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commercial REITs” companies pay a dividend yield of 3.9% and pay out 91.9% of their earnings in the form of a dividend. Biomed Realty Trust has raised its dividend for 7 consecutive years.

Profitability

This table compares Biomed Realty Trust and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biomed Realty Trust 18.98% 3.73% 2.07%
Biomed Realty Trust Competitors 50.91% 4.81% 3.56%

Insider & Institutional Ownership

73.0% of shares of all “Commercial REITs” companies are held by institutional investors. 7.3% of shares of all “Commercial REITs” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Biomed Realty Trust rivals beat Biomed Realty Trust on 8 of the 9 factors compared.

About Biomed Realty Trust

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Receive News & Ratings for Biomed Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomed Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.